Citi Reaffirms Their Buy Rating on Thermo Fisher (TMO)
Citi analyst Patrick B Donnelly maintained a Buy rating on Thermo Fisher today and set a price target of $660.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, B Donnelly is a 4-star analyst with an average return of 4.3% and a 49.68% success rate. B Donnelly covers the Healthcare sector, focusing on stocks such as Exact Sciences, Illumina, and QuidelOrtho.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Thermo Fisher with a $644.00 average price target.
Based on Thermo Fisher’s latest earnings release for the quarter ending September 27, the company reported a quarterly revenue of $11.12 billion and a net profit of $1.62 billion. In comparison, last year the company earned a revenue of $10.6 billion and had a net profit of $1.63 billion
Based on the recent corporate insider activity of 77 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of TMO in relation to earlier this year. Last month, Michel Lagarde, the EVP & COO of TMO sold 22,046.00 shares for a total of $12,424,243.76.
Read More on TMO:
Disclaimer & DisclosureReport an Issue
- Thermo Fisher price target raised to $700 from $650 at BofA
- Thermo Fisher price target raised to $675 from $635 at Wells Fargo
- PayPal downgraded, Roku upgraded: Wall Street’s top analyst calls
- Thermo Fisher upgraded to Buy from Neutral at Citi
- Synopsys upgraded, Warner Bros. downgraded: Wall Street’s top analyst calls
